When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury

Acute kidney injury (AKI) is a common condition in critically ill patients, and may contribute to significant medical, social, and economic consequences, including death. Although there have been advances in medical technology, including continuous renal replacement therapy (CRRT), the mortality rat...

Full description

Bibliographic Details
Main Authors: Jung Nam An, Sung Gyun Kim, Young Rim Song
Format: Article
Language:English
Published: The Korean Society of Nephrology 2021-12-01
Series:Kidney Research and Clinical Practice
Subjects:
Online Access:http://www.krcp-ksn.org/upload/pdf/j-krcp-21-043.pdf
_version_ 1828430475805327360
author Jung Nam An
Sung Gyun Kim
Young Rim Song
author_facet Jung Nam An
Sung Gyun Kim
Young Rim Song
author_sort Jung Nam An
collection DOAJ
description Acute kidney injury (AKI) is a common condition in critically ill patients, and may contribute to significant medical, social, and economic consequences, including death. Although there have been advances in medical technology, including continuous renal replacement therapy (CRRT), the mortality rate of AKI is high, and there is no fundamental treatment that can reverse disease progression. The decision to implement CRRT is often subjective and based primarily on the clinician’s judgment without consistent and concrete guidelines or protocols regarding when to initiate and discontinue CRRT and how to manage complications. Recently, several randomized controlled trials addressing the initiation of renal replacement therapy in critically ill patients with AKI have been completed, but clinical application of the findings is limited by the heterogeneity of the objectives and research designs. In this review, the advantages and disadvantages of CRRT initiation, clinical guideline recommendations, and the results of currently published clinical trials and meta-analyses are summarized to guide patient care and identify future research priorities.
first_indexed 2024-12-10T17:49:08Z
format Article
id doaj.art-1e0507c20c43486faf64e0b99da95534
institution Directory Open Access Journal
issn 2211-9132
2211-9140
language English
last_indexed 2024-12-10T17:49:08Z
publishDate 2021-12-01
publisher The Korean Society of Nephrology
record_format Article
series Kidney Research and Clinical Practice
spelling doaj.art-1e0507c20c43486faf64e0b99da955342022-12-22T01:39:07ZengThe Korean Society of NephrologyKidney Research and Clinical Practice2211-91322211-91402021-12-0140456657710.23876/j.krcp.21.0436074When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injuryJung Nam An0Sung Gyun Kim1Young Rim Song2 Division of Nephrology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea Division of Nephrology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea Division of Nephrology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of KoreaAcute kidney injury (AKI) is a common condition in critically ill patients, and may contribute to significant medical, social, and economic consequences, including death. Although there have been advances in medical technology, including continuous renal replacement therapy (CRRT), the mortality rate of AKI is high, and there is no fundamental treatment that can reverse disease progression. The decision to implement CRRT is often subjective and based primarily on the clinician’s judgment without consistent and concrete guidelines or protocols regarding when to initiate and discontinue CRRT and how to manage complications. Recently, several randomized controlled trials addressing the initiation of renal replacement therapy in critically ill patients with AKI have been completed, but clinical application of the findings is limited by the heterogeneity of the objectives and research designs. In this review, the advantages and disadvantages of CRRT initiation, clinical guideline recommendations, and the results of currently published clinical trials and meta-analyses are summarized to guide patient care and identify future research priorities.http://www.krcp-ksn.org/upload/pdf/j-krcp-21-043.pdfacute kidney injurycontinuous renal replacement therapyguidelinemeta-analysisrandomized controlled trial
spellingShingle Jung Nam An
Sung Gyun Kim
Young Rim Song
When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury
Kidney Research and Clinical Practice
acute kidney injury
continuous renal replacement therapy
guideline
meta-analysis
randomized controlled trial
title When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury
title_full When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury
title_fullStr When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury
title_full_unstemmed When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury
title_short When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury
title_sort when and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury
topic acute kidney injury
continuous renal replacement therapy
guideline
meta-analysis
randomized controlled trial
url http://www.krcp-ksn.org/upload/pdf/j-krcp-21-043.pdf
work_keys_str_mv AT jungnaman whenandwhytostartcontinuousrenalreplacementtherapyincriticallyillpatientswithacutekidneyinjury
AT sunggyunkim whenandwhytostartcontinuousrenalreplacementtherapyincriticallyillpatientswithacutekidneyinjury
AT youngrimsong whenandwhytostartcontinuousrenalreplacementtherapyincriticallyillpatientswithacutekidneyinjury